Fundraising Fox

Christopher Gagliardi

Investor

Investor at Sanofi Ventures · Board director at AdvanCell

Boston, Massachusetts

Writes $5M – $10M checks · typically $7.5M

Find your path to Christopher

68 people in our graph share verified history with Christopher — schools, employers, funds. One of them is your warm intro.

Clay RowlandunlockedChristopher: together at i2O Therapeutics (2024–2025)
×2Christopher: together at NextPoint Therapeutics
×3Christopher: together at MinervaX
×2Christopher: together at AdvanCell

About

Christopher Gagliardi is Ph.D.-trained with a consulting background, serves as Board Observer at Lifordi Immunotherapeutics, and is publicly associated with over 40 life sciences and healthcare investments.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Board director at AdvanCell

Intro paths

→

In turn, Christopher can intro founders to AdvanCell's investors below.

AdvanCell's investors · 9

AbingworthLondon · $15M – $30M checks · since 2026Ally Bridge GroupNew York · since 2026Bain Capital Life SciencesBoston · since 2026Catalio Capital Management, LPNew York · since 2026Proto AxiomSydney · since 2026Sanofi VenturesCambridge · $5M checks · since 2026SV Health InvestorsBoston · $1M – $20M checks · since 2026T. Rowe PriceBaltimore · since 2026Tenmilesince 2026

Co-founders at AdvanCell

AAAndrew Adamovich
Andrew AdamovichDirector

Experience

  1. SanofiPrincipal, Sanofi Venturescurrent2023 — presentGreater Boston
  2. SanofiDirector of Investments, Sanofi Ventures2017 — 2023Greater Boston
  3. QuantX BiosciencesBoard Membercurrent2025 — presentShanghai, China
  4. Diagonal TherapeuticsBoard Observercurrent2026 — presentBoston, Massachusetts, United States
  5. AdvanCellBoard Membercurrent2024 — presentBrisbane, Queensland, Australia
  6. Atalanta TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
  7. Sudo BiosciencesBoard Membercurrent2023 — presentCarmel, Indiana, United States
  8. Minervax ApSBoard Membercurrent2020 — presentCopenhagen, Capital Region of Denmark, Denmark
  9. Avilar TherapeuticsBoard Observercurrent2023 — presentGreater Boston
  10. NextPoint Therapeutics, Inc.Board Observercurrent2022 — presentGreater Boston
  11. Matchpoint TherapeuticsBoard Observercurrent2022 — presentGreater Boston
  12. i2o TherapeuticsBoard Membercurrent2020 — presentGreater Boston
  13. L.E.K. ConsultingConsultant2015 — 2017Greater Boston
  14. Graz University of TechnologyResearch Assistant/Intern, Department of Inorganic Chemistry2006Graz, Austria
  15. Marine Biological LaboratoryMarine Resources Center2005Woods Hole, Massachusetts

Skills & more

Spectroscopy7Electrochemistry4UV/Vis5Life Sciences5Strategy2Financial Modeling1Asset Life Cycle Management1Pharmaceutical Industry2Biotechnology1Revenue Forecasting

Languages I have a basic knowledge of German

From Christopher's professional profile.

Investments

Board seats

AdvanCell

Per SEC Form D filings.

Colleagues at Sanofi Ventures

Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Kriti
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures

Network4

Cris De Luca
Partner, Digital at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Jim Trenkle
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures

Investors connected to Christopher in public investor directories — a warm-intro map.

Frequently asked questions

Who is Christopher Gagliardi?
Christopher Gagliardi is Ph.D.-trained with a consulting background, serves as Board Observer at Lifordi Immunotherapeutics, and is publicly associated with over 40 life sciences and healthcare investments.
Where does Christopher Gagliardi work?
Christopher Gagliardi is Investor at Sanofi Ventures and Board director at AdvanCell.
What does Christopher Gagliardi invest in?
Christopher Gagliardi invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
What check size does Christopher Gagliardi write?
Christopher Gagliardi typically writes checks of $5M – $10M.
What boards does Christopher Gagliardi sit on?
Christopher Gagliardi holds tracked board seats at AdvanCell.
Where did Christopher Gagliardi go to school?
Christopher Gagliardi studied at Harvard University (Postdoctoral Research Fellow); The University of North Carolina at Chapel Hill (Doctor of Philosophy (Ph.D.), Inorganic Chemistry); Roger Williams University (Bachelor of Science (B.S.) Chemistry, Bachelor of Science (B.S.) Biology).

Same school

Also attended Harvard University2,000

Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG

+ 1,994 more

Also attended The University of North Carolina at Chapel Hill364

Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionEric WagnerVP of Research and Data at Redpoint VenturesSoul DayanInvestor at True VenturesAlex LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED Investors

+ 358 more

Also attended Roger Williams University10

Michael ChagnonVice President, Fund Finance at Bain Capital CryptoMatthew RutlerEVP @ MasterClass at Cosmic Venture PartnersTara MeehanAssistant Controller at Rose Park AdvisorsChristian TellesManaging Partner at Expanding CapitalKhouloud TebiniLegal Counsel at SPE Capital PartnersOanh SamDirector, Operations & Experience at Averin Capital

+ 4 more

Shared employers

Also worked at Sanofi150

Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures

+ 144 more

Also worked at Atalanta Therapeutics1

Arno de WildeInvestor at EQT Life Sciences

Also worked at Minervax ApS7

Sten VerlandVenture Partner at Sunstone CapitalPatrik SobockiPractice Lead Deep Tech and Senior Investment Director at IndustrifondenKabeer AzizCo-Founder and Partner at Adjuvant CapitalEmmanuelle CoutanceauPartner at Novo HoldingsVeronica Gambillara FonckPartner at Pureos BioventuresIshaan TewarieVice President at EQT Life Sciences

+ 1 more

Also worked at L.E.K. Consulting185

Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures

+ 179 more